The US Food and Drug Administration (FDA) has extended Regenxbio’s review timeline of the Biologics License Application (BLA) ...

PM ...

AM ...

Omeros' performance has consistently failed to meet expectations, raising concerns about its future prospects. Read more to ...

The accused, Professor Usman Qazi, a government employee with a PhD in Pakistan Studies, is currently under interrogation. He ...

The Election Commission has announced that individuals in Bihar who were omitted from the draft electoral roll published on ...

Dr Habetan and Bugti further claimed that Qazi had acted as a facilitator in the November 2024 Quetta Railway Station bombing ...

In this Healio Video Perspective from the Retina World Congress, Huma Qamar, MD, MPH, of Ocugen, overviews programs for ...

Capricor Therapeutics met with the FDA last week for a type A meeting, during which CEO Linda Marbán aimed to explain to the ...

Despite its SDGT designation in 2019, the Balochistan Liberation Army (BLA) recently faced FTO scrutiny, coinciding with US ...

FDA extends the decision on Regenxbio's RGX-121 for Hunter syndrome to February 2026 following the submission of new ...

During the briefing, a confessional statement of the arrested lecturer named Dr Usman Qazi, who was employed at Balochistan ...